Intellectual property
More’s the Pity – Rules on Distinctiveness
17 April 2019 - Posted by: David Stone
A recent General Court decision emphasises the difficulty of registering slogans as trade marks, including for specialised medical devices. Medrobotics Corp had applied for registration of SEE MORE. REACH MORE. TREAT MORE. as an EU trade mark (Medrobotics v EUIPO T-555/18) in relation to articulated arms and probes for medical diagnostic and surgical use. Medrobotics’ › Read More
25 March 2019 - Posted by: Rafi Allos
In Boehringer Ingelheim v Generics,* the English High Court ordered the rarely-used remedy of pre-action inspection of property, for the purpose of allowing experiments needed to assess patent infringement. The case provides a useful reminder of the powers of the Court in this area, as well as providing a reference as to how the Court › Read More
Key developments in relation to new Chinese IP tribunal rule and Chinese patent law amendment
18 January 2019 - Posted by: David Shen
Recently, there have been some key developments in the intellectual property sphere in China that may be relevant to life sciences clients. Below we report on the new Chinese IP tribunal rule and an important Chinese patent law amendment. New Chinese IP tribunal rule The Standing Committee of the National People’s Congress previously announced the › Read More
09 January 2019 - Posted by: Toby Sears
The Opinion of Advocate General Saugmandsgaard Øe in Abraxis Bioscience (Case C-443/17) was delivered on 13 December 2018. The Advocate General concluded that the UK Intellectual Property Office had been correct in declining to grant a Supplementary Protection Certificate (SPC) to Abraxis for a novel formulation of an active substance which had already been the › Read More
18 December 2018 - Posted by: Eveline Van Keymeulen
By the 1990’s the European Union had fallen behind other developed economies in the encouragement and support its pharmaceutical regulatory framework offered to the development of new treatments for rare diseases. The aim of the Orphan Regulation was to remedy this. In the article “Has the Orphan Regulation Met its Aims? A Critical Examination of the European Union’s › Read More